First Patient in Landmark Clinical Study Evaluating Engineered Macrophages in Humans
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...
275 articles
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...
Stephen Brannan, Chief Medical Officer at Karuna Therapeutics discusses positive data recently published in the New England Journal of Medicine from the...
Jamie Milas, Vice President of Marketing at Medical Microinstruments S.p.A. Learn more on Health Professional Radio.
Lamont, President and Chief Operating Officer at Inteliquet™, a leader in clinical trial matching, discusses the impact COVID has had on clinical tria...
Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology, discusses the positive 12-week primary analysi...
Returned guest, Bruce Boise, author of the book "Cold Comfort: One Man's Struggle to Stop the Illegal Marketing of Powerful Opioid Drugs and Save Lives"...
Scott Megaffin, CEO of Adastra Pharmaceuticals, Inc., a company focused on the treatment of cancers with high unmet needs (such as high-grade gliomas), ...
Robert Davidson, CEO of CURE Pharmaceutical, a drug delivery and development company discusses their delivery platform called CUREform™, which include...
Eiman Shafa, MD, Orthopedic Surgery Specialist in Minneapolis, MN discusses his experience with Medtronic's navigated interbody, disc prep, and Midas Re...
Returned guest, Kent Thoelke, Chief Scientific Officer and Executive Vice President at PRA Health Sciences, a leading pharmaceutical service, healthcare...